Hyperprolactinemia.
The ability to measure serum prolactin levels has led to the characterization of hyperprolactinemia as a clinical entity. In women galactorrhea and amenorrhea are symptoms of elevated prolactin levels; in men, impotence seems to be a clinical correlate. In the differential diagnosis, concern about the presence of a pituitary adenoma is preeminent. Management of microadenomas is controversial; both active therapy and conservative follow-up have been advocated. For larger lesions, neurosurgery or radiation becomes necessary. Drug therapy to reduce prolactin levels is now available.
D000236:Adenoma / Q000097:blood; D001971:Bromocriptine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D010911:Pituitary Neoplasms / Q000097:blood; D011388:Prolactin / Q000097:blood*
D001971:Bromocriptine; D011388:Prolactin